Skip to main content
Top
Published in: Journal of Neural Transmission 10/2018

Open Access 01-10-2018 | Neurology and Preclinical Neurological Studies - Original Article

Clinical pain and functional network topology in Parkinson’s disease: a resting-state fMRI study

Authors: Gwenda Engels, Brónagh McCoy, Annemarie Vlaar, Jan Theeuwes, Henry Weinstein, Erik Scherder, Linda Douw

Published in: Journal of Neural Transmission | Issue 10/2018

Login to get access

Abstract

Pain is an important non-motor symptom in Parkinson’s disease (PD), but its underlying pathophysiological mechanisms are still unclear. Research has shown that functional connectivity during the resting-state may be involved in persistent pain in PD. In the present cross-sectional study, 24 PD patients (both during on and off medication phase) and 27 controls participated. We assessed pain with the colored analogue scale and the McGill pain questionnaire. We examined a possible pathophysiological mechanism with resting-state fMRI using functional network topology, i.e., the architecture of functional connections. We took betweenness centrality (BC) to assess hubness, and global efficiency (GE) to assess integration of the network. We aimed to (1) assess the differences between PD patients and controls with respect to pain and resting-state network topology, and (2) investigate how resting-state network topology (BC and GE) is associated with clinical pain in both PD patients and controls. Results show that PD patients experienced more pain than controls. GE of the whole brain was higher in PD patients (on as well as off medication) compared to healthy controls. GE of the specialized pain network was also higher in PD patients compared to controls, but only when patients were on medication. BC of the pain network was lower in PD patients off medication compared to controls. We found a positive association between pain and GE of the pain network in PD patients off medication. For healthy controls, a negative association was found between pain and GE of the pain network, and also between pain and BC of the pain network. Our results suggest that functional network topology differs between PD patients and healthy controls, and that this topology can be used to investigate the underlying neural mechanisms of pain symptoms in PD.
Literature
go back to reference Beck A, Steer R, Brown G (1996) Beck depression inventory. San Antonio 78:490–498 Beck A, Steer R, Brown G (1996) Beck depression inventory. San Antonio 78:490–498
go back to reference Broyd SJ, Demanuele C, Debener S et al (2009) Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav 33:279–296CrossRef Broyd SJ, Demanuele C, Debener S et al (2009) Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav 33:279–296CrossRef
go back to reference Defazio G, Berardelli A, Fabbrini G et al (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194CrossRefPubMed Defazio G, Berardelli A, Fabbrini G et al (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194CrossRefPubMed
go back to reference Flores J, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E (2004) Opiate anti-nociception is attenuated following lesion og large dopamine neurons of the periaqueductal gray: critical role for D1 (not D2) dopamine receptors. Pain 110:205–214CrossRefPubMed Flores J, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E (2004) Opiate anti-nociception is attenuated following lesion og large dopamine neurons of the periaqueductal gray: critical role for D1 (not D2) dopamine receptors. Pain 110:205–214CrossRefPubMed
go back to reference Fornito A, Zalesky A, Bullmore E (2016) Fundamentals of brain network analysis. Academic Press, Cambridge Fornito A, Zalesky A, Bullmore E (2016) Fundamentals of brain network analysis. Academic Press, Cambridge
go back to reference Hagelberg N, Jääskeläinen S, Martikainen I (2004) Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 500:187–192CrossRefPubMed Hagelberg N, Jääskeläinen S, Martikainen I (2004) Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 500:187–192CrossRefPubMed
go back to reference McGrath P, Seifert CE, Speechley KN et al (1996) A new analogue scale for assessing children’s pain: an initial validation study. Pain 64:435–443CrossRefPubMed McGrath P, Seifert CE, Speechley KN et al (1996) A new analogue scale for assessing children’s pain: an initial validation study. Pain 64:435–443CrossRefPubMed
go back to reference Melzack R (1975) The McGill pain questionnaire: major properties and scoring methods. Pain 1:277–299CrossRefPubMed Melzack R (1975) The McGill pain questionnaire: major properties and scoring methods. Pain 1:277–299CrossRefPubMed
go back to reference Nasreddine Z, Phillips N, Bédirian V (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed Nasreddine Z, Phillips N, Bédirian V (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed
go back to reference Quittenbaum B, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10:129–136CrossRefPubMed Quittenbaum B, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10:129–136CrossRefPubMed
go back to reference Rodríguez-Violante M (2017) Clinical determinants of Parkinson’s disease-associated pain using the King’s Parkinson’s disease pain scale. Mov Disord 4:545–551CrossRef Rodríguez-Violante M (2017) Clinical determinants of Parkinson’s disease-associated pain using the King’s Parkinson’s disease pain scale. Mov Disord 4:545–551CrossRef
go back to reference Silva EG, Viana MA, Quagliato EMAB (2008) Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 66:26–29CrossRefPubMed Silva EG, Viana MA, Quagliato EMAB (2008) Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 66:26–29CrossRefPubMed
go back to reference van der Kloot WA, Oostendorp RAB, van der Meij J, van den Heuvel J (1995) De Nederlandse versie van “McGill pain questionnaire”: een betrouwbare pijnvragenlijst. Ned Tijdschr Geneeskd 139:669–673PubMed van der Kloot WA, Oostendorp RAB, van der Meij J, van den Heuvel J (1995) De Nederlandse versie van “McGill pain questionnaire”: een betrouwbare pijnvragenlijst. Ned Tijdschr Geneeskd 139:669–673PubMed
go back to reference Vanegas H, Schaible HG (2004) Descending control of persistent pain: Inhibitory or facilitatory? Brain Res Rev 46:295–309CrossRefPubMed Vanegas H, Schaible HG (2004) Descending control of persistent pain: Inhibitory or facilitatory? Brain Res Rev 46:295–309CrossRefPubMed
go back to reference Verhage F (1964) Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. van Gorcum, Assen Verhage F (1964) Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. van Gorcum, Assen
Metadata
Title
Clinical pain and functional network topology in Parkinson’s disease: a resting-state fMRI study
Authors
Gwenda Engels
Brónagh McCoy
Annemarie Vlaar
Jan Theeuwes
Henry Weinstein
Erik Scherder
Linda Douw
Publication date
01-10-2018
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 10/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-018-1916-y

Other articles of this Issue 10/2018

Journal of Neural Transmission 10/2018 Go to the issue

Neurology and Preclinical Neurological Studies - Original Article

Body height loss characterizes camptocormia in Parkinson’s disease

High Impact Review in Neuroscience, Neurology or Psychiatry - Review Article

Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?